B
Bridget Williams
Researcher at Monash University
Publications - 16
Citations - 281
Bridget Williams is an academic researcher from Monash University. The author has contributed to research in topics: Population & Hepatitis C. The author has an hindex of 6, co-authored 14 publications receiving 142 citations. Previous affiliations of Bridget Williams include Monash University, Clayton campus & Burnet Institute.
Papers
More filters
Journal ArticleDOI
Passport to freedom? Immunity passports for COVID-19.
TL;DR: This paper makes tentative recommendations for the ethical introduction of immunity passports, which would permit those who test positive for COVID-19 antibodies to return to some of their normal behaviours, such as travelling more freely and returning to work.
Journal ArticleDOI
Role of modelling in COVID-19 policy development.
Emma S. McBryde,Michael T. Meehan,Oyelola A. Adegboye,Adeshina I. Adekunle,Jamie M. Caldwell,Anton Pak,Diana Patricia Rojas,Bridget Williams,James M. Trauer +8 more
TL;DR: Economic evaluation and policies have combined epidemic models and traditional economic models to address the economic consequences of COVID-19, which have informed policy calls for easing restrictions and social contact and mobility models.
Journal ArticleDOI
Modelling insights into the COVID-19 pandemic.
Michael T. Meehan,Diana Patricia Rojas,Adeshina I. Adekunle,Oyelola A. Adegboye,Jamie M. Caldwell,Evelyn M Turek,Bridget Williams,Ben J. Marais,James M. Trauer,Emma S. McBryde +9 more
TL;DR: The critical role played by mathematical modelling to understand COVID-19 thus far is highlighted, the challenges posed by data availability and uncertainty, and the continuing utility of modelling-based approaches to inform the public health response are highlighted.
Journal ArticleDOI
Point-of-care hepatitis C testing from needle and syringe programs: An Australian feasibility study
Bridget Williams,Jessica Howell,Joseph Doyle,Alexander J. Thompson,Bridget Draper,Chloe Layton,Ned Latham,Frances Bramwell,Dean Membrey,Maggie Mcpherson,Janine Roney,Mark Stoove,Margaret Hellard,Alisa Pedrana +13 more
TL;DR: Point-of-care tests may help to overcome some of the barriers preventing people who inject drugs (PWID) accessing testing and progressing to treatment for hepatitis C virus (HCV) as discussed by the authors.
Journal ArticleDOI
Community-based, point-of-care hepatitis C testing: perspectives and preferences of people who inject drugs.
Ned Latham,Ned Latham,Alisa Pedrana,Alisa Pedrana,Joseph Doyle,Joseph Doyle,Joseph Doyle,Jessica Howell,Bridget Williams,Peter Higgs,Peter Higgs,Alexander J. Thompson,Alexander J. Thompson,Margaret Hellard +13 more
TL;DR: Offering point‐of‐care hepatitis C testing at needle syringe programmes is acceptable to PWIDs, however tests that avoid venepuncture are not necessarily the most attractive to PWID.